Implementation of adaptive methods in early-phase clinical trials

DOI10.1002/SIM.6910MaRDI QIDQ7002168zbMATH OpenFDO

Authors Gina R. Petroni, Nolan A. Wages, Gautier Paux, Frédéric Dubois

Publication date 4 April 2025

Published in Statistics in Medicine (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1002/SIM.6910

zbMATH Keywords

adaptive methodsdose-findingprotocol development

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites work

• Bayesian optimal interval designs for phase I clinical trials
• Continual reassessment and related dose-finding designs
• Design efficiency in dose finding studies
• Designs for Single- or Multiple-Agent Phase I Trials
• Miscellanea. A stopping rule for the continual reassessment method
• Operating characteristics of the standard phase I clinical trial design.

Cited in

(1)

• Preface. Early phase dose finding methodology

This page was built for publication: Implementation of adaptive methods in early-phase clinical trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q7002168)